Prenetics Global Limited (PRE) Research

As an investment holding company, Prenetics Global Limited specializes in providing diagnostic and genetic testing services. Its comprehensive product line features CircleDNA, a consumer-oriented genetic analysis solution, and the Circle HealthPod, an advanced health monitoring device. The Circle HealthPod facilitates rapid COVID-19 detection through nucleic acid amplification technology, suitable for both professional point-of-care and personal at-home use. Additionally, the company offers ColoClear, a non-invasive FIT-DNA screening test for colorectal cancer, and Circle SnapShot, a readily available at-home blood testing kit. Other diagnostic solutions in their portfolio include Circle Medical, Circle One, and F1x/Fem. Prenetics Global Limited was founded in 2014 and maintains its headquarters in Quarry Bay, Hong Kong.

Market snapshot

Symbol
PRE
Price
$20.50
Day change
+3.25%
Market cap
$348.5M
P/E ratio
-4.90x
52-week range
7.175-23.63
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Next earnings
in 3 months
Analyst price target
$36.00

Peer companies

  • Armata Pharmaceuticals, Inc. (ARMP)
  • Atlantic International Corp. (ATLN)
  • Codexis, Inc. (CDXS)
  • Insight Molecular Diagnostics Inc. (IMDX)
  • MaxCyte, Inc. (MXCT)
  • OraSure Technologies, Inc. (OSUR)
  • Profound Medical Corp. (PROF)
  • Sangamo Therapeutics, Inc. (SGMO)

Recent insider activity

  • Cheng Yin Pan — M-Exempt (15873 shares) on 2026-06-15
  • Cheng Yin Pan — M-Exempt (15873 shares) on 2026-06-15
  • VANDERVEEN DAVID — M-Exempt (6944 shares) on 2026-06-15
  • VANDERVEEN DAVID — M-Exempt (8681 shares) on 2026-06-15
  • Leogrande Hudson Blake — trade (24004 shares) on 2026-06-04

Open Prenetics Global Limited (PRE) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.